Blog
RSS FeedPosted by Michael Wonder on 30 Nov 2018
New Zealand Pharmaceutical Schedule - 1 December 2018 update
1 December 2018 - The December 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 29 Nov 2018
Decision to remove funding restrictions for alendronate 70 mg products, decrease price, and award sole supply
30 November 2018 - PHARMAC is pleased to announce that the funding restrictions on alendronate 70 mg products will be ...
Posted by Michael Wonder on 31 Oct 2018
New Zealand Pharmaceutical Schedule - 1 November 2018 update
31 October 2018 - The November 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 29 Sep 2018
New Zealand Pharmaceutical Schedule - 1 October 2018 update
1 October 2018 - The October 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 Aug 2018
New Zealand Pharmaceutical Schedule - 1 September 2018 update
1 September 2018 - The September 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Aug 2018
Proposal to list sapropterin for use in pregnancy by women with phenylketonuria
30 August 2018 - PHARMAC is seeking feedback on a proposal to fund sapropterin tablets, a treatment for the rare ...
Posted by Michael Wonder on 27 Aug 2018
Update on proposal to fund a pangenotypic hepatitis C treatment - glecaprevir and pibrentasvir (Maviret)
27 August 2018 - PHARMAC would like to thank everyone who provided feedback on a proposal to fund glecaprevir and ...
Posted by Michael Wonder on 31 Jul 2018
New Zealand Pharmaceutical Schedule - 1 August 2018 update
1 August 2018 - The August 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 12 Jul 2018
New Zealand’s medicines waiting list: international disgrace for patient equity
12 July 2018 - The medicines waiting list grows to over 100 priority medicines that wait to be publicly funded ...
Posted by Michael Wonder on 08 Jul 2018
Notification of dates for entecavir brand switch
9 July 2018 - PHARMAC has announced the listing date and transition timeframes for a brand switch for entecavir from ...
Posted by Michael Wonder on 04 Jul 2018
New osteoporosis treatment set to provide another option for patients
5 July 2018 - Another press release from PHARMAC announcing the listing of a new medicine that should have occurred ...
Posted by Michael Wonder on 30 Jun 2018
New Zealand Pharmaceutical Schedule - 1 July 2018 update
1 July 2018 - The July 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 31 May 2018
New Zealand Pharmaceutical Schedule - 1 June 2018
1 June 2018 - The June 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 08 May 2018
Notification of delay of decision on denosumab funding proposal
8 May 2018 - PHARMAC would like to advise all interested parties that there will be a delay in the ...
Posted by Michael Wonder on 30 Apr 2018
New Zealand Pharmaceutical Schedule - 1 May 2018
1 May 2018 - The May 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...